Global Bio chem Technology : VOTING RESULTS OF RESOLUTION PROPOSED AT EXTRAORDINARY GENERAL MEETING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

GLOBAL BIO-CHEM TECHNOLOGY GROUP COMPANY LIMITED

大 成 生 化 科 技 集 團 有 限 公 司 *

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 00809)

VOTING RESULTS OF RESOLUTION PROPOSED

AT EXTRAORDINARY GENERAL MEETING

The Board is pleased to announce that the ordinary resolution proposed at the EGM was duly passed by way of poll.

Reference is made to the circular of Global Bio-chem Technology Group Company Limited (the "Company") dated 22 November 2019 (the "Circular"). Terms used herein shall have the same meanings as defined in the Circular unless the context requires otherwise.

VOTING RESULTS OF THE EGM

The board (the "Board") of directors of the Company (the "Directors") is pleased to announce that the following ordinary resolution (the "Resolution") was duly passed by the Shareholders by way of poll at the EGM held on 12 December 2019:

Resolution	Number of votes (%)
FOR	AGAINST
To ratify, confirm and approve the subscription agreement dated	3,144,821,022	6,000
27 September 2019 (the "Subscription Agreement") entered	Shares	Shares
into between the Company and HK Bloom Investment Limited in	(99.99%)	(0.01%)
respect of the issue of 1,228,607,685 new shares of the Company
(the "Subscription Shares") and the transaction contemplated
thereunder, and the granting of a specific mandate to the Directors
to allot and issue the Subscription Shares pursuant to the terms
and conditions of the Subscription Agreement.

- 1 -

As at the date of the EGM, the total issued share capital of the Company was HK$767,879,803.2 divided into 7,678,798,032 Shares in the capital of the Company.

Pursuant to rule 14A.36 of the Listing Rules, any shareholder with a material interest in the relevant connected transaction is required to abstain from voting on the relevant resolution at the EGM. The Subscriber who holds 1,279,799,672 Shares as at the date of the EGM has abstained from voting on the Resolution. There was no Share entitling the Shareholders to attend and vote only against the Resolution at the EGM. The total number of Shares entitling the Shareholders to attend and vote for or against the Resolution at the EGM was 6,398,998,360, representing approximately 83.3% of the total issued share capital of the Company as at the date of the EGM.

The Company's branch share registrar, Tricor Tengis Limited, was appointed as the scrutineer at the EGM for the vote-taking.

Yours faithfully,

For and on behalf of the Board

Global Bio-chem Technology Group Company Limited

Yuan Weisen

Chairman

Hong Kong, 12 December 2019

As at the date of this announcement, the Board comprises three executive Directors, namely, Mr. Yuan Weisen, Mr. Zhang Zihua and Mr. Liu Shuhang; one non-executive Director, namely, Ms. Liang Wanpeng; and three independent non-executive Directors, namely, Mr. Ng Kwok Pong, Mr. Yeung Kit Lam and Mr. Zhao Jin.

• For identification purpose only

- 2 -